Difficulty: Medium
Average Score: 84%
Practice
Which of the following antienzymes is an aromatase inhibitor used in cancer therapy?
Correct answer
D
Rationale
The correct answer is D) Aminoglutethimide. Aminoglutethimide is an aromatase inhibitor commonly used in cancer therapy, specifically in the treatment of hormone-sensitive breast cancer. Aromatase inhibitors work by blocking the enzyme aromatase, which converts androgens into estrogens. By inhibiting this process, aminoglutethimide helps reduce estrogen levels in the body, which can slow down or inhibit the growth of estrogen-dependent tumors.
Option A) Physostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and glaucoma. Option B) Allopurinol is a xanthine oxidase inhibitor used in the treatment of gout. Option C) Aminocaproic acid is an antifibrinolytic agent used to treat excessive bleeding.
Understanding the mechanisms of action of different drugs is essential in pharmacology to ensure safe and effective medication administration. In the context of safety pharmacology across the lifespan, knowing the specific uses and actions of medications is crucial for providing appropriate care to patients of all ages. This knowledge helps healthcare professionals make informed decisions regarding drug selection, dosing, and monitoring to optimize patient outcomes.
Option A) Physostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and glaucoma. Option B) Allopurinol is a xanthine oxidase inhibitor used in the treatment of gout. Option C) Aminocaproic acid is an antifibrinolytic agent used to treat excessive bleeding.
Understanding the mechanisms of action of different drugs is essential in pharmacology to ensure safe and effective medication administration. In the context of safety pharmacology across the lifespan, knowing the specific uses and actions of medications is crucial for providing appropriate care to patients of all ages. This knowledge helps healthcare professionals make informed decisions regarding drug selection, dosing, and monitoring to optimize patient outcomes.